11-K 1 a2082947z11-k.txt 11-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ------------------------------------- FORM 11-K ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One:) [x] ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (NO FEE REQUIRED) For the fiscal year ended December 31, 2001 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (NO FEE REQUIRED) For the transition period from ____________ to ____________ Commission file number: 000-21326 A. Full title of the plan and the address of the plan, if different from that of the issuer named below: Anika Therapeutics, Inc. Employee Savings and Retirement Plan B. Name of issuer of the securities held pursuant to the plan and the address of its principal executive office: Anika Therapeutics, Inc. 236 West Cummings Park Woburn, MA 01801 (781) 932-6616 REQUIRED INFORMATION Item 4. Plan financial statements and schedule for the year ended December 31, 2001 have been prepared in accordance with the financial reporting requirements of ERISA.
PAGE NUMBER IN THIS REPORT -------------- Statements of Net Assets Available for Benefits as of December 31, 2001 and 2000 F-1 Statement of Changes in Net Assets Available for Benefits for the year ended December 31, 2001 F-2
Signature THE PLAN. Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees have duly caused this annual report to be signed on their behalf by the undersigned hereunto duly authorized. Anika Therapeutics, Inc. Employee Savings and Retirement Plan By: /s/ Douglas R. Potter ----------------------------------- Douglas R. Potter, Trustee Dated: June 27, 2002 Anika Therapeutics, Inc. Employee Savings & Retirement Plan STATEMENTS OF NET ASSETS AVAILABLE FOR BENEFITS AS OF DECEMBER 31, 2001 and 2000
2001 2000 INVESTMENTS Participant directed, at fair value - Money market fund $ 297,788 $ 193,325 Employer common stock 68,422 57,259 Mutual funds 1,229,504 1,238,389 Participant loans 84,839 100,074 ---------- ---------- Total investments 1,680,553 1,589,047 CONTRIBUTIONS RECEIVABLE 22,396 13,556 ---------- ---------- NET ASSETS AVAILABLE FOR BENEFITS $1,702,949 $1,602,603 ========== ==========
F-1 Anika Therapeutics, Inc. Employee Savings & Retirement Plan STATEMENT OF CHANGES IN NET ASSETS AVAILABLE FOR BENEFITS FOR THE YEAR ENDED DECEMBER 31, 2001
2001 Interest & dividends $ 44,430 ---------- Contributions by: Employees 296,121 Employer 186,870 Rollover distributions, net (7,594) ---------- Total contributions 475,397 ---------- Total additions 519,827 ---------- Less: Distributions to former participants 215,187 ---------- Net increase (decrease) before realized gains and losses 304,640 Net realized and unrealized investment gains and losses (204,294) ---------- Net decrease in net assets 100,346 Net assets available for benefits, beginning of year 1,602,603 ---------- Net assets available for benefits, end of year $1,702,949 ==========
F-2